GSK chief science officer leaves to join US startup

By Frank Prenesti

Date: Wednesday 19 Jan 2022

(Sharecast News) - GlaxoSmithKline said it had appointed Tony Wood as chief scientific officer designate after Hall Barron said he was resigning the post to run a new privately owned start-up biotech company.

.
Wood, who joined GSK from Pfizer in 2017, will take over on August 1. Barron is joining Altos Labs, a new biotech company based in San Francisco, California as chief executive and co-chair.

Altos is focused on the biology of cellular rejuvenation programming with the goal of reversing disease, GSK said.

« Go back to news channel

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE